3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
CNS
1
Conditions
Neoplasms
11
Prostatic Neoplasms
10
Breast Neoplasms
8
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lung Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Renal Cell
3
Thrombocythemia, Essential
2
Testicular Neoplasms
2
Stomach Neoplasms
2
Skin Diseases
2
Primary Myelofibrosis
2
Polycythemia Vera
2
Myeloproliferative Disorders
2
Melanoma
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Hodgkin Disease
2
Hematologic Diseases
2
Glioma
2
Burkitt Lymphoma
2
Breast Neoplasms, Male
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Uveal Melanoma
1
Interventions
Surveys and Questionnaires
15
Radiosurgery
14
Magnetic Resonance Imaging
11
Magnetic Resonance Spectroscopy
10
Neuropsychological Tests
8
Radiotherapy
7
Radiation
4
Blood Specimen Collection
4
Patient Reported Outcome Measures
3
sacituzumab govitecan
2
Trastuzumab
2
Surgical Procedures, Operative
2
Quality of Life
2
Physical Examination
2
Phlebotomy
2
Perfusion Magnetic Resonance Imaging
2
Lead
2
Lapatinib
2
Interviews as Topic
2
Immunotherapy
2
Drug Therapy
2
Data Collection
2
Brain Mapping
2
Bevacizumab
2
Amplified Fragment Length Polymorphism Analysis
2
Aminolevulinic Acid
2
trastuzumab deruxtecan
1
pembrolizumab
1
osimertinib
1
lorlatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Brain Neoplasms
×
Watchful Waiting
×
Clear all
NCT05375617
2025-05-31
EPICkids
Columbia University
Recruiting
1,400 enrolled